Literature DB >> 17895356

Selection of patients for liver transplantation and allocation of donated livers in the UK.

J Neuberger1, A Gimson, M Davies, M Akyol, J O'Grady, A Burroughs, M Hudson.   

Abstract

BACKGROUND: The increasing shortfall between the number of patients who would benefit from liver transplantation and the availability of donor livers means that rationing has to occur. The processes of selection of patients for transplantation and for allocation of donor livers should be done according to ethical and, where possible, evidence-based criteria so that there is clarity and that the competing requirements of equity, justice, utility and benefit can be balanced.
METHODS: To achieve these goals for patients in the United Kingdom in need of transplantation, we have developed guidelines for the selection of patients to the national waiting list based on the risk of death without a transplant and the ability of the procedure to improve the recipient's quality of life. Guidelines have been developed for both those with acute liver failure and chronic liver disease. Allocation will depend on matching of the donor liver to the recipient.
RESULTS: The proposed system, to be introduced into the UK compares with some other systems, where different models for selection and allocation have been introduced.

Entities:  

Mesh:

Year:  2007        PMID: 17895356     DOI: 10.1136/gut.2007.131730

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  49 in total

1.  Studies on avian erythrocyte metabolism--I. Procedure for separation and quantitation of the major phosphorylated metabolic intermediates by anion exchange chromatography.

Authors:  R E Isaacks; D R Harkness; G A Froeman; S A Sussman
Journal:  Comp Biochem Physiol A Comp Physiol       Date:  1976-01

2.  Amyloidosis and subacute liver failure.

Authors:  Moby Joseph; Timothy J S Cross
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-03

3.  Futility and rationing in liver retransplantation: when and how can we say no?

Authors:  Scott W Biggins
Journal:  J Hepatol       Date:  2012-02-04       Impact factor: 25.083

Review 4.  Transplantation as disease modifying therapy in adults with inherited metabolic disorders.

Authors:  Sandra Sirrs; Fady Hannah-Shmouni; Stephen Nantel; James Neuberger; Eric M Yoshida
Journal:  J Inherit Metab Dis       Date:  2018-02-01       Impact factor: 4.982

5.  How regenerative medicine and tissue engineering may complement the available armamentarium in gastroenterology?

Authors:  Marco Carbone; Jan Lerut; James Neuberger
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

Review 6.  Acute and acute severe (fulminant) autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2012-10-23       Impact factor: 3.199

7.  Living donor liver transplantation for high model for end-stage liver disease score: What have we learned?

Authors:  Hany Dabbous; Mohammad Sakr; Sara Abdelhakam; Iman Montasser; Mohamed Bahaa; Hany Said; Mahmoud El-Meteini
Journal:  World J Hepatol       Date:  2016-08-08

8.  Acute liver failure.

Authors:  Mohammed A Arshad; Nicholas Murphy; Mansoor N Bangash
Journal:  Clin Med (Lond)       Date:  2020-09       Impact factor: 2.659

9.  Pre-liver transplant biopsy in hepatocellular carcinoma: a potential criterion for exclusion from transplantation?

Authors:  Richard S Young; Mohammed Aldiwani; Abdul R Hakeem; Amit Nair; Ashley Guthrie; Judy Wyatt; Darren Treanor; Gareth Morris-Stiff; Rebecca L Jones; K Rajendra Prasad
Journal:  HPB (Oxford)       Date:  2012-12-27       Impact factor: 3.647

10.  Short-term independent mortality risk factors in patients with cirrhosis undergoing cardiac surgery.

Authors:  Juan Carlos Lopez-Delgado; Francisco Esteve; Casimiro Javierre; Xose Perez; Herminia Torrado; Maria L Carrio; David Rodríguez-Castro; Elisabet Farrero; Josep Lluís Ventura
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-12-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.